background: The Fallopian tube (FT) is the site of fertilization and early embryonic development. We have previously reported the expression of activins, their receptors and follistatin by the FT. Here, our aim was to study the expression of tubal activins, their type II receptors and follistatin during the menstrual cycle and following exposure to hCG in vivo.
Introduction
The Fallopian tube (FT) is biologically active and provides an optimum environmental medium that supports and enhances fertilization and early embryonic development (Tazuke and Giudice, 1996; Hunter, 1998) . Several groups have demonstrated an improvement in the morphological development of the embryo and rate of hatching with improved implantation after embryo co-culture on feeder layers of human oviductal cells and sequential oviductal-endometrial cells (Bongso et al., 1994; Vlad et al., 1996; Ghosh and Sengupta, 1998; Weichselbaum et al., 2002) .
Activins are dimeric polypeptide growth factors that belong to the transforming growth factor-b (TGF-b) superfamily. Activins are homodimers of two b-subunits (bA and bB) ,and the different dimerization of subunits gives rise to three glycoproteins: activin-A (bA-bA), activin-B (bB-bB) and activin-AB (bA-bB) (Refaat et al., 2004) . They act through serine/threonine kinase transmembrane receptors resulting in phosphorylation of intracellular mediators, Smads, to initiate their action on different target cells (Refaat et al., 2004) . Follistatin is the main regulator of the local bioactivity of activins since binding of activin to follistatin is almost irreversible (Refaat et al., 2004) .
Several studies have suggested a role for activins and their related molecules in early embryonic development. Addition of activin-A to culture media enhanced the development of 1-cell embryos into morulae through the 4-cell stage in mice (Lu et al., 1993) . Activin-A also enhanced maturation, and subsequent post-cleavage development and blastocyst formation, of bovine oocytes during in vitro maturation (Silva and Knight, 1998; Yoshioka et al., 1998) . Other studies have confirmed stage-specific expression-for example, follistatin mRNA was expressed early in the gastrula stage of xenopus embryos (Thomsen et al., 1990) and in peri-and post-implantation mouse blastocysts (Lu et al., 1993; Jones et al., 2006b) . Additionally, none of the activin subunits were detected in human preimplantation embryos from the 4-cell to the morula stage, and only the bA-subunit was detected in blastocyst embryos. However, activin type II receptors were detectable in all of the studied embryos (He et al., 1999) , suggesting that early human embryos are capable of responding to, but not producing, activins.
Gene manipulation studies have reported that both activin bA and bB-subunits are involved in embryo development and suggest that activin bA-subunit plays a more important role in embryogenesis (Vassalli et al., 1994; Matzuk et al., 1995) . Furthermore, the response to replacement of the bA-subunit by bB-subunit in bA 2/2 mice suggests distinct functions for each activin isoform during development and that activin bA and bB-subunits do not functionally overlap in all settings in vivo (Brown et al., 2003) . Most studies on the expression of activins in the oviduct have been carried out in animal species (Lu et al., 1993; Gandolfi et al., 1995) . For both activin subunits, mRNA and protein expression vary in a cycledependent manner in the oviduct of non-pregnant cycling mice (Jones et al., 2006b) . The authors suggested that the predominant source of activin b-subunits during the estrous cycle and preimplantation phase were the epithelial cells lining the oviduct and endometrium.
We have previously demonstrated the expression of activin subunits, type II receptors and follistatin in premenopausal human FT (Bahathiq et al., 2002; Refaat et al., 2004) and we have recently reported an increase in the expression of tubal activin-A in FT bearing an ectopic pregnancy (EP) (Refaat et al., 2008 ). We therefore have suggested that activins may participate in the processes of fertilization, early embryo development and transport in the FT in a paracrine/autocrine mechanism (Bahathiq et al., 2002; Refaat et al., 2004) . Furthermore, we have suggested that hCG promotes tubal receptivity by modulating the expression of several tubal proteins, including activins (Refaat et al., 2008 Al-Azemi et al., 2009 .
Our aim was to examine the expression of activin subunits, their receptors and follistatin in human FTs collected from the different stages of the menstrual cycle and in tubes collected from pseudopregnant women. Demonstration of different expression profiles of activins and their related molecules by tubal epithelial cells during the cycle and following hCG injection would support the hypothesis that these molecules are involved in the earliest stages of conception and that hCG modulates tubal activins.
Materials and Methods

Patients and tissue collection
The study was approved by South Sheffield Ethics Committee (04/ Q2305/25), and informed written consent was obtained prior to the collection of tissue samples. All specimens were collected between 2005 and 2007 at the Jessop Wing, Royal Hallamshire Hospital in Sheffield, UK.
Menstrual cycle group
A set of 24 FTs were collected at the different phases of the cycle (n ¼ 4 in each stage) from 12 cyclic women (median age 34 years, range 28 -40 years) who were undergoing routine total abdominal hysterectomy (TAH) for benign disease not affecting the FTs. All women had regular menstrual cycles, were of proved fertility with no evidence of tubal disease and were not taking exogenous hormones.
Estradiol (E2) and progesterone (P) were measured using enzyme-linked immunosorbent Assay (ELISA) kits from Eagle Biosciences, Inc. (Boston, USA), and all samples were processed in duplicate according to the manufacturer's instructions. For E2, functional sensitivity was 16.8 pmol/l, and intra-and inter-assay variabilities were 6 and 7.5%, respectively. For P, functional sensitivity was 0.125 nmol/l, and intra-and inter-assay variabilities were 6 and 8%, respectively. The manufacturer's reference ranges for E2 during the cycle phases were 100-367 pmol/l for early follicular, 370-1468 pmol/l for late follicular and 183.5-550.5 pmol/l for luteal phase. The manufacturer's reference ranges for P during the cycle phases were ,15 nmol/l for non-luteal phase and 3.15-110 nmol/l for luteal phase.
Endometrial biopsies were collected immediately following TAH to histologically confirm the stage of the cycle, according to the criteria of Noyes et al. (1950) . The follicular stage was identified by small glands with a smooth outer surface and lined with a single cuboidal epithelium showing mitosis, and the stroma was highly impacted with cells. The luteal phase was characterized by irregular glands in shape and size and full with secretion, lined by columnar epithelium and the stroma was oedematous with cellular decidualization. The menstrual phase was identified by fragmented endometrial glands and stroma with late secretory changes and showing areas of haemorrhage and polymorphus cellular infiltrate (Noyes et al., 1950) .
'Pseudo-pregnancy' group
Since it is not ethically possible to collect FTs from women carrying a healthy pregnancy, we studied six FTs collected from three women at the time of hysterectomy following injection with hCG as described previously (Refaat et al., 2008; Al-Azemi et al., 2009 ). An endometrial biopsy and a blood sample were collected at the time of hysterectomy to examine endometrial decidualization and hCG concentrations and the state of pseudo-pregnancy was confirmed as described previously (Refaat et al., 2008; Al-Azemi et al., 2009 .
Sampling and processing
The ampullary and isthmic regions of the excised tubes were identified and each region was immediately cut into three equal pieces using RNAse-free equipment (baked at 2008C for 4 h). One piece was immediately fixed in 10% buffered formalin for 24 h at room temperature, dehydrated with a series of different ethanol concentrations and embedded in paraffin for immunohistochemistry.
The other parts were immersed in 5 ml of RNAlater solution (Ambion, UK) and stored at 2808C to preserve their RNA stability for quantitative RT-PCR. Prior to RNA extraction, the specimen was thawed and fixed in 10% buffered formalin for 24 h at room temperature, dehydrated with a series of different ethanol concentrations and embedded in paraffin for laser microdissection of tubal epithelial cells.
Antibodies
Monoclonal antibodies to detect activin bA-(E4) and bB-(C5) subunits were obtained from Serotec Ltd. (Oxford, UK) and monoclonal antibodies for follistatin were from R&D systems (Abingdon, UK). Polyclonal antibodies to detect the activin receptor type IIA (N-17) and type IIB (N-16) were obtained from Santa-Cruz Biotechnology Inc. (Heidelberg, Germany).
Immunohistochemistry
The immunohistochemistry protocol was as described previously (Refaat et al., 2004 (Refaat et al., , 2008 . Archived rat ovaries were used as a positive control and the negative control slide consisted of a section of the Expression of activins in human Fallopian tube tissue block being studied, which was treated identically to all other slides, with the exception that the primary antibody was omitted to control for non-specific binding of the detection system. A positive reaction was characterized by the presence of brown staining. Each section was examined by two observers who were blinded to the source of tissue and they agreed on the intensity of staining according to the following semiquantitative scale: (0) negative; (1) equivocally positive; (2-4) weakly positive; (5 -7) positive; (8-10) strongly positive. Representative sections were photographed using an Olympus digital camera at ×400 magnification.
Laser capture microscopy
For investigation of mRNA expression levels, epithelial cells from the different segments of the FT were microdissected using a laser capture microdissector (Arcturus, Herts, UK) as described previously (Refaat et al., 2008 cDNA synthesis RNA extraction from microdissected tubal epithelial cells and synthesis of the first complementary DNA (cDNA) were performed as described previously (Refaat et al., 2008 ) using the RNeasy FFPE Kit (QIAGEN Ltd, Crawley, UK) and the RETROscript kit (Applied Biosystems, Warrington, UK), respectively.
Quantitative PCR
PCR was performed with the cDNAs, power SYBR green master mix (Applied Biosystems, Warrington, UK) and primers from Metabion (Table I ). The quantitative PCR was carried out as described previously (Refaat et al., 2008 . Universal human RNA (Stratagene, Amsterdam, Netherlands) was used as a positive control and two negative controls were included, one with no reverse transcription (minus-RT) to control for the previous step and one with no PCR template, containing all the PCR components but with water used as a template. All experiments were performed in triplicate.
Results were analyzed using Mx3000P (Stratagene, Hemel Hempstead, UK). Relative expression of the target genes were compared between the different stages of the cycle and pseudo-pregnancy. The threshold cycle values were normalized against threshold value of human b-actin, and the data were analyzed using the formula 2
2DDCT
. Ct is the cycle number at which the PCR signal crosses a designated threshold. The DCT is the difference between the Ct value for the target gene and the internal normalization control (b-actin). DDCT is the difference between the DCT and the control standard mentioned above.
Statistical analysis
Normality was evaluated with Kolmogorov-Smirnov test, and due to the non-normality distribution of data, we used The Mann-Whitney U-test to compare between the different groups. Statistical significance was accepted when P , 0.05.
Results
All endometrial samples from the different stages of the cycle were consistent for the patient's reported last menstrual period, steroid hormones concentrations (Table II) and histological stage (data not shown). Pseudo-pregnancy was confirmed by the persistence of amenorrhea, the presence of a corpus luteum and decidualization of the endometrium as described previously (Refaat et al., 2008; Al-Azemi et al., 2009 .
Immunohistochemistry
All antibodies for all activin subunits, type II receptors and follistatin clearly stained the granulosa cells in the archived rat ovary (data not shown). Negative controls failed to show any positive reaction (data not shown).
In general, the antibodies against activin bA-subunit (Fig. 1A, C, E and G), bB-subunit (Fig. 1B, D , F and H), follistatin ( Fig. 2A -D) , type IIA receptor (Fig. 2E -H ) and type IIB receptor (Fig. 2I-L showed a similar pattern of immunoreactivity in the oviduct throughout the cycle and in pseudo-pregnancy. All molecules were localized in the cytoplasm of the tubal cells, with the exception of activin type IIB receptor, which was found to be expressed in both the cytoplasm and the nucleus in some, but not all, cells.
The expression of all molecules varied with the different stages of the cycle and in pseudo-pregnancy (Table III) , being weakest in follicular phase, maximal in luteal phase and decreased in the menstrual phase and pseudo-pregnancy but at levels higher than the follicular phase (Figs 1 and 2) . Additionally, the nuclear expression of activin type IIB receptor showed a similar profile during the different stages of the cycle and in pseudo-pregnant tubes (Fig. 2I -L) .
Quantitative RT-PCR
Results from b-actin (data not shown) failed to show any statistically significant variation between the different samples (P . 0.05), which indicates that the loading of RNA from the different samples was similar.
Using the 2 2DDCt method, mRNA expression results were normalized against b-actin and expressed as fold-change compared with the follicular phase. The mRNA of all molecules was significantly up-regulated during the luteal phase when compared with the other phases of the cycle (P , 0.05; Fig. 3 ). The increase in mRNA expression for all molecules during the luteal phase was consistent with the results obtained from immunohistochemistry. Additionally, the administration of hCG in mid-luteal phase rescued the mRNA expression of candidate molecules from falling to the follicular phase levels (P , 0.05). However, the expression of activin bA-subunit and activin IIA receptor was still significantly lower than in the luteal phase ( Fig. 3A and C) .
Discussion
We have previously reported the ability of the FT to express activin bA-and bB-subunits, activin type II receptors and follistatin in premenopausal women (Bahathiq et al., 2002; Refaat et al., 2004) . The present study is the first to demonstrate a dynamic expression of activin bA-and bB-subunits, type IIA and IIB receptors and follistatin during different stages of the menstrual cycle. The expression of candidate molecules was weakest during the follicular phase and reached its maximum during the luteal phase where early stages of conception take place. A decline in the expression of these molecules was observed in the menstrual phase but the expression remained higher than in the follicular phase. Furthermore, we are the first to report the effect of hCG on the expression of candidate molecules by the tubal epithelial cells in vivo. Administration of hCG from midluteal rescued the expression of candidate molecules from dropping to the follicular stage levels, while the level of expression for all molecules was lower than the levels of the luteal phase. These results were shown at the mRNA and protein levels by quantitative RT -PCR and immunohistochemistry. A limitation of our study is that it presents data from a small sample size (12 cycling and 3 pseudo-pregnant patients), and increasing the number of participants would increase the statistical power of the study. However, previous published reports investigating the expression of several molecules, including activins and their related molecules, by the human endometrium and FT during either the menstrual cycle and/or pseudo-pregnancy generated their results from a similar sample size, emphasizing the difficulties of patient recruitment (Florio et al., 2003; Al-Azemi et al., 2009 ). Nevertheless, we were able to detect a significant difference Figure 1 Immunohistochemical expression of activin bA-subunit (left column) and activin bB-subunit (right column) in FT specimens collected during the follicular stage (first row, A and B), luteal stage (second row, C and D), menstrual stage (third row, E and F) and pseudo-pregnancy (fourth row, G and H). All parts ×400. Scale bar ¼ 5 mm for all parts.
Expression of activins in human Fallopian tube between the different groups when compared with the follicular phase (P , 0.05) at the mRNA and protein levels, suggesting that these candidate molecules are involved in the regulation of the tubal physiology.
Additionally, there was a considerable interval between collection and analysis of the specimens of up to 3 years; expression of the studied molecules may have altered during this time. However, specimens were stored under controlled and monitored conditions at 2808C and no frozen specimen was thawed/refrozen more than once to minimize the negative impact of prolonged fixation and/or storage on the candidate molecules.
A further limitation of the study is that immunohistochemistry is a semiquantitative and subjective technique, and it lacks standardization. Thus, discrepancies in the results may arise from inter-and/or intraobserver variations in the interpretation of the immunostains (Walker, 2006) . However, immunohistochemistry is widely used in routine diagnostic work and for scientific research in pathology and cytology, and we suggest that the observed differences were sufficiently striking to be unlikely to be due to variability in different observers' interpretations.
The tubal epithelium has two different cells types, ciliated and secretory cells and they undergo changes in both morphological features and number during the menstrual cycle in response to estrogen and progesterone (Crow et al., 1994) . The FT mucosa is subject to high concentrations of progesterone due to a countercurrent exchange mechanism between the ovarian artery and the venous plexuses along the mesosalpinx, and the influx of follicular fluid also exposes FT epithelium to high levels of ovarian steroids at midcycle (Einer-Jensen and Hunter, 2000) . An increase in the secretory cell population is seen during the luteal phase, and secretory materials are accumulated in these cells and then released into the lumen to support the oocyte, sperm and preimplantation embryo (BonillaMusoles et al., 1983) .
Variability of activin bA-and bB-subunit expression in the endometrium during the different stages of the cycle has been shown. Both subunits increased significantly in human endometrium through the cycle, being highest in the luteal phase of the cycle (Leung et al., 1998; Mylonas et al., 2004) . These authors suggested that both b-subunits may play an essential role in endometrial maturation (Leung et al., 1998; Mylonas et al., 2004) . Activins are secreted in mouse oviductal fluid (Lu et al., 1993) and both activin bA-and bB-subunits mRNA and protein expression fluctuate in a cycledependent manner in the oviduct of cycling mice (Jones et al., 2006b) . Additionally, infusion of progesterone into the ovarian artery of gilts significantly increased plasma concentration of activin-A in the ipsilateral ovarian vein (Wasowska and Stefanczyk-Krzymowska, 2010) . The present work is consistent with the previous observations and suggests that tubal activins and their related molecules are modulated by ovarian steroids and participate in the regulation of tubal physiology in a paracrine/autocrine manner.
In vitro incubation of sperm with tubal epithelial cells has been shown to facilitate capacitation (Ellington et al., 1993) , enhance and maintain sperm motility (Yao et al., 1999) , induce the acrosome reaction (Ellington et al., 1993) and enhance sperm binding to the zona pellucida (Ellington et al., 1993) . In vitro studies have also shown that direct physical contact between sperm and tubal epithelial cells enhances the sperm motility and velocity, and these effects were inhibited when a microporous membrane prevented cell-to-cell contact between sperm and FT epithelial cells, suggesting that the tubal epithelium secretes factors that support the biology of the sperm and the fertilization process (Kervancioglu et al., 2000) . Although activins are involved in the biology of the sperm and oocyte (Bahathiq et al., 2005) , there is no report in the literature and our results does not provide clear evidence on whether activins are involved in the process of fertilization. Therefore, prospective in vitro studies should investigate whether tubal activins have a role in fertilization.
The oocyte and preimplantation human embryos are not able to synthesize activins as indicated by the mRNA of these proteins being not detected until the morula stage (Sidis et al., 1998; He et al., 1999) . However, activin type II receptor is detected during the earlier stages (Sidis et al., 1998; He et al., 1999) , suggesting that the human preimplantation embryo can respond to, but not synthesize, activins. Additionally, deletion of the bA-and/or bB-subunit genes in mouse resulted in congenital malformations and death of mutant mice (Brown et al., 2003) . Therefore, it has been suggested that the absence of activin during preimplantation embryo development is compensated by maternally derived activins, which are expressed in the surrounding tissues such as tubal epithelium (Sidis et al., 1998; He et al., 1999) . The detection of activin subunits in mouse oviductal epithelial cells and oviductal fluid is also consistent with a role for maternally derived activins in promoting preimplantation embryo development (Lu et al., 1993; Jones et al., 2006b) .
Our results support the animal studies and suggest that the tubal epithelium generates the proper microenvironment necessary for early embryonic development by increasing the expression of both activin subunits by tubal epithelial cells during the luteal phase where preimplantation embryonic development takes place within the uterine tube in vivo. Our results also suggest that human FT is able to synthesize activin-A, activin-B and activin-AB. However, the dual expression of both subunits by tubal epithelium does not necessarily confirm the ability of these cells to assemble or secrete the different activin ligands. Future studies should investigate the presence of the different activin isoforms in human tubal fluid and to compare the expression of the different activin subunits within the same cell population of tubal epithelium. Additionally, the co-expression of activin subunits, receptors and binding protein suggests that tubal epithelium is capable of responding to activins and that there is tight local regulation of activin activity within the FT. However, identification of their intracellular mediators, the various Smads, is still needed to confirm that tubal activins regulate the FT in a paracrine/autocrine action.
Both tubal ciliary beats and tubal contractions are believed to be essential for successful transport of the embryo along the tube and to ensure delivery of the embryo at the endometrial cavity at the optimum time for adhesion and implantation (Lyons et al., 2006) . It is becoming increasingly evident that the mechanism of tubal transport is much more complex than first thought and can be affected by a wide range of factors and conditions that may impair fertility and lead to EP (Refaat et al., 2008) . Tubal ciliary beat is regulated by sex hormones, growth factors and cytokines (Lyons et al., 2006; Al-Azemi et al., 2010) . At the present time, there is no report on the effect of activins on tubal ciliary beat frequency and smooth muscle contraction. Our results showed that activin subunits, activin type II receptors and follistatin are located in the cytoplasm of all tubal epithelial cells, including ciliated cells, and therefore we suggest that activins may play a role in the regulation of tubal peristalsis. Nevertheless, further studies are needed to investigate the effect of activins on tubal ciliary beat frequency.
There is strong evidence to suggest that activins are involved in the process of intrauterine implantation (Jones et al., 2006a) Expression of activins in human Fallopian tube pathogenesis of EP (Refaat et al., 2008 ). Activin-A up-regulates matrix metalloproteinases in human endometrial cells in vitro and therefore it could facilitate the process of trophoblast invasion (Jones et al., 2006a) . Moreover, the expression of activin by the cytotrophoblast is low, which suggests that trophoblast invasion is induced by maternally derived activin (Jones et al., 2006a) . The expression of activin-A and follistatin is dynamic and up-and down-regulated during the process of decidualization (Jones et al., 2006a) . In vitro studies have also reported that activin-A modulates the expression of adhesive molecules by the human trophoblast (Stoikos et al., 2010) . EP is a form of abnormal pregnancy and the majority are located within the FT. We have previously reported that the expression of activin-A and its related molecules is higher in FTs bearing an EP when compared with pseudo-pregnant controls (Refaat et al., 2008) . Furthermore, we have shown their involvement in the microbialmediated immune response to Chlamydia trachomatis infection in tubes collected from EP, and we have suggested that their pathological expression may lead to tubal damage and the development of EP . Therefore, we have hypothesized that failure of the tubal transport machinery will retain the blastocycst within the tube and overexposes tubal epithelium to embryonic chorionic gonadotrophin (CG). The increasing amounts of embryonic CG secreted into tubal milieu from the blastocyst stage onwards induce receptivity in the tubal epithelium by modulating the expression of several tubal proteins, leading to ectopic implantation (Refaat et al., 2008; Al-Azemi et al., 2009 .
CG is the key embryonic signal that acts on endometrial epithelium to promote implantation (Filicori et al., 2005) . The earliest expression of CG protein by the human embryo occurs at the blastocyst stage when the embryo is normally located in the uterine cavity for implantation (Jurisicova et al., 1999) . CG mediates its action by binding to the LH receptor (Filicori et al., 2005) , which has been localized in several extragonadal reproductive tissues, including human Fallopian tubal epithelial cells (Lei et al., 1993) . Furthermore, the HCG/LH receptor, localized in human FT, has shown variation during the cycle. The highest expression was observed during the luteal phase and it was predominant in the ampullary segment where the majority of ectopic pregnancies occur (Lei et al., 1993) .
The present work shows that hCG injection at the mid-luteal phase of the cycle rescued the expression of tubal activins from falling to the follicular phase levels, suggesting that hCG is able to modulate the expression of tubal activins and their related molecules.
In conclusion, we suggest that tubal activins and their related molecules are involved in the regulation of tubal physiology in a paracrine/autocrine action. The observed increase in the expression of candidate molecules during the luteal phase suggests that activins may have a role in fertilization and in preimplantation embryo development in human. Our results also suggest that hCG modulates the expression of activins and their related molecules.
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